Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 4,632,149 | 4,632,149 | 0 | $309.57M | $192.60M | 57.63% | -$116.96M |
| Foghorn Therapeutics Inc.(FHTX) | 12,674,120 | 12,674,120 | 0 | $118.00M | $59.82M | 17.90% | -$58.17M |
| Sana Biotechnology, Inc.(SANA) | 25,001,856 | 25,001,856 | 0 | $104.01M | $40.75M | 12.19% | -$63.25M |
| Omega Therapeutics Inc | 29,225,579 | 29,225,579 | 0 | $35.66M | $21.79M | 6.52% | -$13.86M |
| Seres Therapeutics, Inc.(MCRB) | 23,117,045 | 23,117,045 | 0 | $21.87M | $19.25M | 5.76% | -$2.62M |
| Syros Pharmaceuticals Inc | 1,293,849 | 0 | -1,293,849 | $2.78M | $0 | — | -$2.78M |